Customer
Veriskin is a medical device company that specializes in skin cancer screening. Veriskin has built a custom handheld gadget that helps physicians and non-expert users determine whether a suspect skin lesion is cancerous without an invasive biopsy.
- BUSINESS NAME Veriskin Inc.
- LOCATION USA
- BUSINESS ACTIVITY Technology-assisted healthcare delivery
Problem
Veriskin decided to build a novel device that uses Machine Learning algorithms for non-invasive skin cancer detection. They turned to Softeq to test the viability of their idea through proof of concept (PoC) and develop firmware components powering the device.
Solution
The solution is a complex Wi-Fi-enabled system that incorporates:
- FPGA-powered handheld device based on the Qualcomm Snapdragon SD410 processor complete with LEDs
- Embedded software
- Hardware components: audio speaker, accelerometer, and display among others.
Equipped with 2 photodetectors and a force sensor, the solution captures LED light signal variations and translates them into a visual diagram in real time.
To diagnose the suspect lesion’s condition, the system monitors vascular refilling rate and proceeds to the custom algorithmic data analysis complete with a plain report output on the UI.
The solution’s highlights include:
- Audiovisual guide with error messaging
- Calibrated LED lights maximizing photodetector sensitivity
- Memory capacity for 100+ test results downloadable via the USB or BLE
- Custom Linux BSP and drivers
- Built-in flash memory-based software
- Optimized Linux boot-time
- Firmware updates via the USB
- Secure login (SSH protocol)
Results
Currently, the system is under rigorous clinical testing across the US dermatological institutions. The studies demonstrate that the device proves efficient in determining cancerous lesions. The solution is capable of detecting malignant skin growth in 96.7% of suspect cases with no extra biopsies or examinations. Allowing for a low-cost and prompt cancer diagnostics method, the device is meant to cut healthcare-associated spendings.